Rory S. Wolfe

553 St Kilda Road
Melbourne, VIC 3004, Australia

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 355 publications

Atorvastatin, Cardiovascular Events, and Disability-free Survival in Older Adults.

Atorvastatin, Cardiovascular Events, and Disability-free Survival in Older Adults.

Journal: The New England journal of medicine

Published: August 31, 2026

Longitudinal Changes in Heart Stress and the Risk for Cardiovascular Disease and Mortality in Older Adults : An Observational Study.

Longitudinal Changes in Heart Stress and the Risk for Cardiovascular Disease and Mortality in Older Adults : An Observational Study.

Journal: Annals of internal medicine

Published: August 17, 2026

Identifying Risk-De-Escalating Markers in PREVENT-Defined Intermediate-Risk Older Adults: Insights From ASPREE.

Identifying Risk-De-Escalating Markers in PREVENT-Defined Intermediate-Risk Older Adults: Insights From ASPREE.

Journal: Circulation. Population health and outcomes

Published: July 02, 2026

Identifying Risk-De-Escalating Markers in PREVENT-Defined Intermediate-Risk Older Adults: Insights From ASPREE.

Identifying Risk-De-Escalating Markers in PREVENT-Defined Intermediate-Risk Older Adults: Insights From ASPREE.

Journal: Circulation. Population health and outcomes

Published: July 02, 2026

Heterogeneity of Treatment Effect of Aspirin and Clinically Significant Bleeding in Older Adults.

Heterogeneity of Treatment Effect of Aspirin and Clinically Significant Bleeding in Older Adults.

Journal: medRxiv : the preprint server for health sciences

Published: June 22, 2026

The role of Lipoprotein(a) and oxidized phospholipids in modifying the effects of aspirin on major cardiovascular events and bleeding in the ASPirin in Reducing Events in the Elderly (ASPREE) randomized clinical trial: Statistical analysis plan.

The role of Lipoprotein(a) and oxidized phospholipids in modifying the effects of aspirin on major cardiovascular events and bleeding in the ASPirin in Reducing Events in the Elderly (ASPREE) randomized clinical trial: Statistical analysis plan.

Journal: medRxiv : the preprint server for health sciences

Published: June 04, 2026

Long-term systolic blood pressure time in target and risk of cardiovascular events in older adults: a secondary analysis of the ASPREE cohort.

Long-term systolic blood pressure time in target and risk of cardiovascular events in older adults: a secondary analysis of the ASPREE cohort.

Journal: American journal of hypertension

Published: May 12, 2026

Cognitive Decline Preceding Incident Cardiovascular Events in Older Adults.

Cognitive Decline Preceding Incident Cardiovascular Events in Older Adults.

Journal: JAMA network open

Published: April 20, 2026

Treating Hearing Loss With Hearing Aids for the Prevention of Cognitive Decline and Dementia.

Treating Hearing Loss With Hearing Aids for the Prevention of Cognitive Decline and Dementia.

Journal: Neurology

Published: March 20, 2026

Integration of lipidomic and polygenic risk scores within contemporary clinical cardiovascular risk assessment pathways: a multi-cohort development and validation study.

Integration of lipidomic and polygenic risk scores within contemporary clinical cardiovascular risk assessment pathways: a multi-cohort development and validation study.

Journal: EClinicalMedicine

Published: February 23, 2026

Evaluating Long-Term Outcomes Across eGFR Equations in Older Adults.

Evaluating Long-Term Outcomes Across eGFR Equations in Older Adults.

Journal: Kidney international reports

Published: February 18, 2026

Cancer Incidence and Mortality With Aspirin in Older Adults: Follow-Up of the ASPREE Trial.

Cancer Incidence and Mortality With Aspirin in Older Adults: Follow-Up of the ASPREE Trial.

Journal: JAMA oncology

Published: January 29, 2026

Showing 1-12 of 355

Last Updated: 09/26/2026